BOSTON — This is an official press release from the U.S. Department of Justice (USAO - Massachusetts), published as received.
BOSTON – A former Massachusetts emergency medical technician (EMT) paramedic has pleaded guilty to tampering with liquid fentanyl vials at the ambulance company at which she worked.
Candice Mangan, 43, of Medford, pleaded guilty on Aug. 30, 2022 in federal court in Boston to one count of tampering with a consumer product. U.S. District Court Chief Judge F. Dennis Saylor IV scheduled sentencing for Dec. 7, 2022. Mangan was charged on June 24, 2022.
From approximately March 2020 to early October 2020, Mangan – a licensed EMT paramedic in Massachusetts – worked part-time as an EMT for an ambulance service company in Massachusetts. On or about Sept. 30, 2020, while working in Needham, Mangan tampered with three fentanyl citrate vials by removing fentanyl citrate and replacing it with saline. The liquid remaining in the three vials contained only approximately 4.4%, 6.8%, and 24.2% of the declared concentration of fentanyl citrate.
“The grave consequences of the opioid crisis extend far beyond street level dealing of heroin and fentanyl, which continues at an alarming pace. Almost every one of the 15 units in the Criminal and Civil Divisions of this Office are handling matters relating to the opioid epidemic,” said United States Attorney Rachael Rollins. “Aside from the obvious opioid related matters handled by our narcotics and organized crime units, we are also prosecuting human trafficking and health care fraud as well as civil rights government fraud and public corruption cases all directly pertaining to opioids. There is no higher priority in my office than doing everything in our power, using every option available on both the civil and criminal sides of this office, to keep people and communities safe from these deadly destructive substances.”
“The FDA oversees the U.S. drug supply to ensure that it is safe and effective, and those who knowingly tamper with medicines put patients’ health at risk,” said Fernando P. McMillan, Special Agent in Charge of the U.S. Food and Drug Administration, Office of Criminal Investigations, New York Field Office. “We will continue to protect the public health and bring to justice health care professionals who take advantage of their unique position and compromise their patients’ health and comfort by tampering with needed drugs.”
The charging statute provides for a sentence of up to 10 years in prison, three years of supervised release and a fine of $250,000. Sentences in a criminal case are imposed by a federal district court judge based upon the U.S. Sentencing Guidelines and statutes which govern the determination of a sentence in a criminal case.
U.S. Attorney Rollins, FDA SAC McMillan and Margret R. Cooke, Commissioner of the Massachusetts Department of Public Health made the announcement today. Assistant U.S. Attorney Howard Locker of Rollins’ Health Care Fraud Unit is prosecuting the case.
